Biography:
Khursheed Nadeem Anwer, Ph.D., M.B.A., is Executive Vice President & Chief Science Officer at IMUNON Inc. since June 2014. Dr. Anwer has served as President and Chief Science Officer of EGEN, Inc. from 2009 until June 2014 when he successfully led the merger of EGEN, Inc. with IMUNON Inc. Dr. Anwer has over 25 years of experience in the discovery and development of gene-based therapeutics. He is the inventor on over one hundred U.S. and international patents, recipient of NIH and FDA funding, and has authored about fifty peer reviewed scientific publications in his active career in research and development.
Title : A DNA-based Vaccine Technology Independent of a Virus or Device
Title : Immunogenicity of DNA Vaccines based on Multicistronic Vectors and Synthetic DNA Delivery Systems